Pyrexar Medical was invited to participate in the Hanoi 2018 - Investment and Development Cooperation event. This year's event included twenty four MoUs (Memoranda of Understanding) and investment certificates at a total value of 270 trillion VND (approx. $12 billion USD). During the ceremony, Pyrexar received an award from the ministry of heath and signed an agreement to deliver hyperthermia systems to government hospitals this year.
Around 1,500 representatives, including leaders of the government, ministries, international organizations and hundreds of investors and businesses were in attendance. The conference is a chance for the government to meet domestic and foreign investors, representatives of embassies, and international organizations, to attract more domestic and foreign investments in Hanoi and the rest of the country.
A special thank you to our new distributor for Vietnam, Cambodia and Laos, Thai Thinh Medical of Hanoi City, for making this opportunity happen. The result; Pyrexar successfully signed agreements for placement of two BSD-500 Superficial Hyperthermia systems, a BSD-2000 Deep Regional Hyperthermia system and our newest BSD-2000 3D/MR Image Guided Thermal Therapy system to Hanoi High Tech and Digestive Center at St. Paul's Hospital and VinMec International Hospital, in Hanoi.
###
ABOUT PYREXAR MEDICAL:
Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR Hyperthermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effectiveness of radiotherapy, chemotherapy and immunotherapy, without increasing toxicity to healthy tissues.